, Volume 97, Issue 1, pp 155-156
Date: 30 Aug 2009

New methods to assess trends in neuro-oncological care

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access
This is an excerpt from the content

To the Editors:

We read with great interest the topical review article by Curry and Barker [1]. The authors wonderfully summarized more than a decade of work in the literature, highlighting racial, ethnic, and socioeconomic disparities in the incidence, pathobiology, and outcomes of brain tumor patients. We would like to add a few salient points to this important discussion.

As we begin to mark the 10-year anniversary of the era which brought us the landmark reports To Err Is Human and Crossing the Quality Chasm, clinicians and scholars across the nation continue to seek novel approaches to providing improved access to high-quality healthcare by reducing disparities [2, 3]. The last decade has seen a dizzying rise in technological innovation and specialization. However, despite the growth of centers of excellence with state-of-the-art diagnostic and therapeutic capabilities for patients with brain tumors, one is left to wonder whether the quality chasm has truly narrowed despite an ever ...